Neuropsychopharmacology - Table of Contents alert Volume 39 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 39, Issue 6 (May 2014) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Circumspectives from Neuropsychopharmacology: scientific debates with a twist.  Read the inaugural Circumspectives article in which eminent addiction researchers reignite their famous decades-long scientific disagreement, centered on their opposing views about what motivates addictive behavior. Read the article now and decide for yourself. Review Top Deep Brain Stimulation of the Human Reward System for Major Depression—Rationale, Outcomes and Outlook Thomas E Schlaepfer, Bettina H Bewernick, Sarah Kayser, Rene Hurlemann and Volker A Coenen Neuropsychopharmacology 2014 39: 1303-1314; advance online publication, February 11, 2014; 10.1038/npp.2014.28 Abstract | Full Text Original Articles Top Parental THC Exposure Leads to Compulsive Heroin-Seeking and Altered Striatal Synaptic Plasticity in the Subsequent Generation Henrietta Szutorisz, Jennifer A DiNieri, Eric Sweet, Gabor Egervari, Michael Michaelides, Jenna M Carter, Yanhua Ren, Michael L Miller, Robert D Blitzer and Yasmin L Hurd Neuropsychopharmacology 2014 39: 1315-1323; advance online publication, January 2, 2014; 10.1038/npp.2013.352 Abstract | Full Text White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis Philip R Szeszko, Delbert G Robinson, Toshikazu Ikuta, Bart D Peters, Juan A Gallego, John Kane and Anil K Malhotra Neuropsychopharmacology 2014 39: 1324-1331; advance online publication, October 16, 2013; 10.1038/npp.2013.288 Abstract | Full Text Reconciling Variable Findings of White Matter Integrity in Major Depressive Disorder Ki Sueng Choi, Paul E Holtzheimer, Alexandre R Franco, Mary E Kelley, Boadie W Dunlop, Xiaoping P Hu and Helen S Mayberg Neuropsychopharmacology 2014 39: 1332-1339; advance online publication, December 19, 2013; 10.1038/npp.2013.345 Abstract | Full Text Influence of RGS2 on Sertraline Treatment for Social Anxiety Disorder Murray B Stein, Aparna Keshaviah, Stephen A Haddad, Michael Van Ameringen, Naomi M Simon, Mark H Pollack and Jordan W Smoller Neuropsychopharmacology 2014 39: 1340-1346; advance online publication, October 24, 2013; 10.1038/npp.2013.301 Abstract | Full Text A Hypothesis-Driven Association Study of 28 Nuclear-Encoded Mitochondrial Genes with Antipsychotic-Induced Weight Gain in Schizophrenia Vanessa F Gonçalves, Clement C Zai, Arun K Tiwari, Eva J Brandl, Andriy Derkach, Herbert Y Meltzer, Jeffrey A Lieberman, Daniel J Müller, Lei Sun and James L Kennedy Neuropsychopharmacology 2014 39: 1347-1354; advance online publication, November 7, 2013; 10.1038/npp.2013.312 Abstract | Full Text Evidence for a Role of Transporter-Mediated Currents in the Depletion of Brain Serotonin Induced by Serotonin Transporter Substrates OPEN Michael H Baumann, Simon Bulling, Tova S Benaderet, Kusumika Saha, Mario A Ayestas, John S Partilla, Syed F Ali, Thomas Stockner, Richard B Rothman, Walter Sandtner and Harald H Sitte Neuropsychopharmacology 2014 39: 1355-1365; advance online publication, November 28, 2013; 10.1038/npp.2013.331 Abstract | Full Text Rapid Anxiolytic Effects of a 5-HT4 Receptor Agonist Are Mediated by a Neurogenesis-Independent Mechanism Indira Mendez-David, Denis J David, Flavie Darcet, Melody V Wu, Saadia Kerdine-Römer, Alain M Gardier and René Hen Neuropsychopharmacology 2014 39: 1366-1378; advance online publication, November 28, 2013; 10.1038/npp.2013.332 Abstract | Full Text Attenuated Insular Processing During Risk Predicts Relapse in Early Abstinent Methamphetamine-Dependent Individuals Joshua L Gowin, Katia M Harlé, Jennifer L Stewart, Marc Wittmann, Susan F Tapert and Martin P Paulus Neuropsychopharmacology 2014 39: 1379-1387; advance online publication, December 6, 2013; 10.1038/npp.2013.333 Abstract | Full Text Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder Manisha Madhoo, Richard SE Keefe, Robert M Roth, Angelo Sambunaris, James Wu, Madhukar H Trivedi, Colleen S Anderson and Robert Lasser Neuropsychopharmacology 2014 39: 1388-1398; advance online publication, December 6, 2013; 10.1038/npp.2013.334 Abstract | Full Text Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial Kamilla W Miskowiak, Maj Vinberg, Ellen M Christensen, Jens D Bukh, Catherine J Harmer, Hannelore Ehrenreich and Lars V Kessing Neuropsychopharmacology 2014 39: 1399-1408; advance online publication, December 10, 2013; 10.1038/npp.2013.335 Abstract | Full Text Forebrain-Specific CRF Overproduction During Development is Sufficient to Induce Enduring Anxiety and Startle Abnormalities in Adult Mice Mate Toth, Jodi E Gresack, Debra A Bangasser, Zach Plona, Rita J Valentino, Elizabeth I Flandreau, Isabelle M Mansuy, Emilio Merlo-Pich, Mark A Geyer and Victoria B Risbrough Neuropsychopharmacology 2014 39: 1409-1419; advance online publication, December 11, 2013; 10.1038/npp.2013.336 Abstract | Full Text The Role of the Nucleus Accumbens Shell in the Mediation of the Reinforcing Properties of a Safety Signal in Free-Operant Avoidance: Dopamine-Dependent Inhibitory Effects of d-amphetamine Anushka BP Fernando, Gonzalo P Urcelay, Adam C Mar, Tony A Dickinson and Trevor W Robbins Neuropsychopharmacology 2014 39: 1420-1430; advance online publication, December 12, 2013; 10.1038/npp.2013.337 Abstract | Full Text Subjective, Physiological, and Cognitive Responses to Intravenous Nicotine: Effects of Sex and Menstrual Cycle Phase Elise E DeVito, Aryeh I Herman, Andrew J Waters, Gerald W Valentine and Mehmet Sofuoglu Neuropsychopharmacology 2014 39: 1431-1440; advance online publication, December 18, 2013; 10.1038/npp.2013.339 Abstract | Full Text Cannabinoid Receptor Activation Shifts Temporally Engendered Patterns of Dopamine Release Erik B Oleson, Roger Cachope, Aurelie Fitoussi, Kimberly Tsutsui, Sharon Wu, Jacqueline A Gallegos and Joseph F Cheer Neuropsychopharmacology 2014 39: 1441-1452; advance online publication, December 18, 2013; 10.1038/npp.2013.340 Abstract | Full Text 12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive–Compulsive Disorder Paul J Grant, Lisa A Joseph, Cristan A Farmer, David A Luckenbaugh, Lorraine C Lougee, Carlos A Zarate, Jr and Susan E Swedo Neuropsychopharmacology 2014 39: 1453-1459; advance online publication, December 19, 2013; 10.1038/npp.2013.343 Abstract | Full Text The Knockout of Secretin in Cerebellar Purkinje Cells Impairs Mouse Motor Coordination and Motor Learning Li Zhang, Sookja Kim Chung and Billy Kwok Chong Chow Neuropsychopharmacology 2014 39: 1460-1468; advance online publication, December 19, 2013; 10.1038/npp.2013.344 Abstract | Full Text HDAC Inhibitors Restore the Capacity of Aged Mice to Respond to Haloperidol through Modulation of Histone Acetylation Janitza L Montalvo-Ortiz, Jack Keegan, Christopher Gallardo, Nicolas Gerst, Kazuhiro Tetsuka, Chris Tucker, Mitsuyuki Matsumoto, Deyu Fang, John G Csernansky and Hongxin Dong Neuropsychopharmacology 2014 39: 1469-1478; advance online publication, December 24, 2013; 10.1038/npp.2013.346 Abstract | Full Text Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use Romina Mizrahi, Miran Kenk, Ivonne Suridjan, Isabelle Boileau, Tony P George, Kwame McKenzie, Alan A Wilson, Sylvain Houle and Pablo Rusjan Neuropsychopharmacology 2014 39: 1479-1489; advance online publication, December 24, 2013; 10.1038/npp.2013.347 Abstract | Full Text Differential Effects of Systemic Cholinergic Receptor Blockade on Pavlovian Incentive Motivation and Goal-Directed Action Selection Sean B Ostlund, Alisa R Kosheleff and Nigel T Maidment Neuropsychopharmacology 2014 39: 1490-1497; advance online publication, December 27, 2013; 10.1038/npp.2013.348 Abstract | Full Text Amphetamine-Induced Dopamine Release and Neurocognitive Function in Treatment-Naive Adults with ADHD Mariya V Cherkasova, Nazlie Faridi, Kevin F Casey, Gillian A O'Driscoll, Lily Hechtman, Ridha Joober, Glen B Baker, Jennifer Palmer, Alain Dagher, Marco Leyton and Chawki Benkelfat Neuropsychopharmacology 2014 39: 1498-1507; advance online publication, December 30, 2013; 10.1038/npp.2013.349 Abstract | Full Text Deleterious Effects of a Low Amount of Ethanol on LTP-Like Plasticity in Human Cortex Caroline Lücke, Tonio Heidegger, Mirjam Röhner, Stefan W Toennes, Lucia Krivanekova, Florian Müller-Dahlhaus and Ulf Ziemann Neuropsychopharmacology 2014 39: 1508-1518; advance online publication, January 2, 2014; 10.1038/npp.2013.350 Abstract | Full Text Serotonin Depletion Induces ‘Waiting Impulsivity’ on the Human Four-Choice Serial Reaction Time Task: Cross-Species Translational Significance Yulia Worbe, George Savulich, Valerie Voon, Emilio Fernandez-Egea and Trevor W Robbins Neuropsychopharmacology 2014 39: 1519-1526; advance online publication, January 2, 2014; 10.1038/npp.2013.351 Abstract | Full Text Sex Differences in Guanfacine Effects on Drug Craving and Stress Arousal in Cocaine-Dependent Individuals Helen C Fox, Peter T Morgan and Rajita Sinha Neuropsychopharmacology 2014 39: 1527-1537; advance online publication, January 7, 2014; 10.1038/npp.2014.1 Abstract | Full Text Long-Term Reduction of Cocaine Self-Administration in Rats Treated with Adenoviral Vector-Delivered Cocaine Hydrolase: Evidence for Enzymatic Activity Natalie E Zlebnik, Stephen Brimijoin, Yang Gao, Amy T Saykao, Robin J Parks and Marilyn E Carroll Neuropsychopharmacology 2014 39: 1538-1546; advance online publication, January 10, 2014; 10.1038/npp.2014.3 Abstract | Full Text Advertisement The value of alcohol - a free podcast from Neuropsychopharmacology.  The latest Brainpod examines the unique motifs of brain activity that may contribute to the pathologically increased value that addicted individuals place on alcohol. Listen now for free. Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.